Six Simcere Products Honored by CPIA

On 14 November, the ChemPharm Annual Summit 2017 was held in Xiamen. During the summit, several charts were revealed.

Simcere ranks 20 in terms of comprehensive competitiveness in China chemical pharmaceutical industry. At the same time, four products are on the list of excellent anti-tumor and immunological products, namely Recombinant Human Endostatin Injection (Endostar), Nedaplatin for Injection (JieBaiShu), Fluorouracil Implants (Sinofuan) and Palonosetron Hydrochloride Injection (Lowvo). On top of these awarded products, Edaravone Injection (BiCun) is awarded excellent CNS product brand, Amoxicillin Granules (ZaiLin) excellent pediatric drug brand.


Related News